Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen

This publication has 22 references indexed in Scilit:

• An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane
  Cancer, 2002
• Survival in three dimensions
  Nature, 2002
• Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study
  Journal of Clinical Oncology, 2002
• Endocrine-responsive breast cancer and strategies for combating resistance
  Nature Reviews Cancer, 2002
• The role of letrozole (Femara(R)) in breast cancer therapy: A clinical review
  Drugs of Today, 2001
• Evaluation of the mechanism of aromatase cytochrome P450
  European Journal of Biochemistry, 2001
• Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
  Proceedings of the National Academy of Sciences, 1998
• Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids
  European Journal Of Cancer, 1997
• Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976